CICCOLI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 7.060
EU - Europa 5.903
AS - Asia 1.187
AF - Africa 16
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 14.185
Nazione #
US - Stati Uniti d'America 7.038
GB - Regno Unito 1.655
IE - Irlanda 1.008
CN - Cina 836
SE - Svezia 677
UA - Ucraina 677
RU - Federazione Russa 463
DE - Germania 442
IT - Italia 374
FR - Francia 300
SG - Singapore 198
FI - Finlandia 188
TR - Turchia 44
ES - Italia 40
VN - Vietnam 34
BE - Belgio 22
CA - Canada 22
JP - Giappone 14
CZ - Repubblica Ceca 13
IR - Iran 13
CI - Costa d'Avorio 12
NL - Olanda 8
EU - Europa 7
IN - India 7
GR - Grecia 5
SA - Arabia Saudita 5
AT - Austria 4
AU - Australia 4
AZ - Azerbaigian 4
LV - Lettonia 4
AM - Armenia 3
AR - Argentina 3
HK - Hong Kong 3
IL - Israele 3
KG - Kirghizistan 3
PK - Pakistan 3
PL - Polonia 3
BD - Bangladesh 2
BG - Bulgaria 2
BR - Brasile 2
CO - Colombia 2
CY - Cipro 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IM - Isola di Man 2
KZ - Kazakistan 2
ZA - Sudafrica 2
AL - Albania 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 14.185
Città #
Southend 1.537
Fairfield 1.157
Dublin 1.001
Chandler 604
Ashburn 590
Woodbridge 558
Jacksonville 552
Seattle 444
Houston 437
Wilmington 434
Cambridge 414
Ann Arbor 306
Nanjing 195
Beijing 193
Princeton 188
Siena 157
Singapore 153
Boardman 99
San Diego 80
Helsinki 77
San Mateo 64
Nanchang 63
Moscow 51
New York 45
Shenyang 45
Izmir 42
Hebei 37
Málaga 37
Dearborn 34
Dong Ket 32
Jiaxing 32
Changsha 30
Jinan 29
Shanghai 29
Tianjin 28
Los Angeles 26
London 25
Kunming 23
Menlo Park 23
Brussels 22
Ningbo 19
Norwalk 19
Munich 18
Washington 18
Florence 16
Rome 16
Dallas 15
Lancaster 15
Milan 15
Zhengzhou 13
Abidjan 12
San Francisco 12
Hangzhou 11
Philadelphia 11
Tokyo 11
Mestre 10
Toronto 10
Redwood City 9
Brno 8
Changchun 8
Guangzhou 8
Auburn Hills 7
Fremont 7
Hefei 7
Padova 7
Düsseldorf 6
Fuzhou 6
Lanzhou 6
Ottawa 6
Saint Petersburg 5
Santa Clara 5
Taizhou 5
Zanjan 5
Andover 4
Chiswick 4
Edinburgh 4
Empoli 4
Ferrara 4
Monteriggioni 4
New Bedfont 4
Newark 4
Riga 4
Riyadh 4
Sacramento 4
Stockholm 4
Venezia 4
Vienna 4
Amsterdam 3
Anguillara Sabazia 3
Baku 3
Baotou 3
Bishkek 3
Bologna 3
Chicago 3
Falkenstein 3
Ferrara di Monte Baldo 3
Hong Kong 3
Islamabad 3
Kilburn 3
Nagoya 3
Totale 10.334
Nome #
Abnormal N-glycosylation pattern for brain nucleotide pyrophosphatase-5 (NPP-5) in Mecp2-mutant murine models of Rett syndrome 238
Revealing the complexity of a monogenic disease: rett syndrome exome sequencing 225
Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation 219
Effects of 50 Hz electromagnetic fields on rat cortical synaptosomes 215
NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsy 204
Alteration of serum lipid profile, SRB1 loss, and impaired Nrf2 activation in CDKL5 disorder 201
Erythrocyte Cytoskeletal-plasma Membrane Protein Network in Rett Syndrome: effects of ω-3 Polyunsaturated Fatty Acids 193
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 187
Beta-actin deficiency with oxidative posttranslational modifications in Rett syndrome erythrocytes: insights into an altered cytoskeletal organization 183
Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome 175
Sindrome di Rett: effetti degli acidi grassi polinsaturi omega-3 sulle proteine di membrana 172
F(2)-Isoprostanes in soft oral tissues and degree of oral disability after mandibular third molar surgery 164
The role of preoperative oxidative stress and mandibular third molar postoperative outcome. 163
Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementation 161
F(4)-neuroprostanes mediate neurological severity in Rett syndrome 160
NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells 159
The effects of hypoxia/reoxygenation on the physiological behaviour of U373-MG astrocytes 158
Persistent Unresolved Inflammation in the Mecp2-308 Female Mutated Mouse Model of Rett Syndrome 157
Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidation 153
F2-Dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome 152
Increased levels of 4HNE-protein plasma adducts in Rett syndrome 149
Erythrocyte shape abnormalities, membrane oxidative damage, and β-actin alterations: an unrecognized triad in classical autism 149
Inflammatory lung disease in Rett syndrome 147
Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns 146
The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period 146
Subclinical inflammatory status in Rett syndrome 145
MECP2 duplication syndrome: Evidence of enhanced oxidative stress. A comparison with Rett syndrome 144
Isoprostanoids in clinical and experimental neurological disease models 144
Red blood cells in Rett syndrome: oxidative stress, morphological changes and altered membrane organization 143
Ethanol-induced oxidative stress: basic knowledge 143
Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients 142
Acrolein or phenylhydrazine-induced iron release and its relationships with oxidative damage in erythrocytes. 142
Systemic oxidative stress in classic Rett syndrome 142
Proteomic analysis of the Rett syndrome experimental model mecp2Q63X mutant zebrafish 141
Iron release in erythrocytes and plasma nonprotein-bound iron in hypoxic and non hypoxic newborns 141
Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs 140
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome 140
Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients 139
F(2)-Dihomo-isoprostanes and Rett syndrome 139
Detection of carbonyl functions in phospholipids of liver microsomes in CCl4- and BrCCl3-poisoned rats 137
UVA light stimulates the production of cathepsin G and elastase-like enzymes by dermal fibroblasts: a possible contribution to the remodeling of elastotic areas in sun-damaged skin 137
A plasma proteomic approach in Rett syndrome: classical versus preserved speech variant 134
Measurement of lipid peroxidation in vivo: a comparison of different procedures 133
Relationship between lipid and purine metabolism: the behavior of fatty acids in plasma triglycerides of gouty patients 131
4HNE protein adducts in autistic spectrum disorders: Rett syndrome and autism 130
Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron 130
Iron release in newborn and adult erythrocytes exposed to hypoxia-reoxygenation 129
Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation 129
The role of oxidative stress in Rett syndrome: an overview 129
Free iron, total F2-isoprostanes and total F4-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin 128
Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation 128
Fatty acid pattern of the erythrocyte lipids and plasma vitamin e in the first days of life 127
Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver 127
Rett syndrome: An autoimmune disease? 127
Oxidative stress and autologous immunoglobulin G binding to band 3 dimers in newborn erythrocytes 124
Biomarkers of lipid oxidative damage in Rett syndrome 124
Morphological changes and oxidative damage in Rett Syndrome erythrocytes 124
Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline 123
Iron released from an erythrocyte lysate by oxidative stress is diffusible and in redox active form 122
Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil 122
Variations of fatty acid composition of erythrocyte and plasma lipids in the rat during the first period of life 121
Immune Dysfunction in Rett Syndrome Patients Revealed by High Levels of Serum Anti-N(Glc) IgM Antibody Fraction 121
Iron release, lipid peroxidation, and morphological alterations of erythrocytes exposed to acrolein and phenylhydrazine 120
Scavenger receptor B1 post-translational modifications in Rett syndrome 120
Hypoxia-induced post-translational changes in red blood cell protein map of newborns 119
Iron release and erythrocyte damage in allyl alcohol intoxication in mice 118
Acidi grassi polinsaturi ω-3 e stato infiammatorio subclinico nella sindrome di Rett: Un approccio proteomico 117
Plasma F2-isoprostanes are elevated in newborns and inversely correlated to the gestational age 115
Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age 115
Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism 114
Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone 113
Iron and erythrocytes: physiological and pathophysiological aspects 110
Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients 109
Hypoxia affects the physiological behaviour of rat cortical synaptosomes 106
Effects of ω-3 polyunsaturated fatty acids on plasma proteome in Rett syndrome 106
Fatty Acids and Autism Spectrum Disorders: The Rett Syndrome Conundrum 106
Markers of oxidative stress in diabetic patients 104
Neuroprostanes and neurological severity in Rett syndrome 104
Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity 103
Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder 103
Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome 102
Pathology of perinatal brain damage: background and oxidative stress markers 102
Oxidative stress and autologous IgG binding to band 3 dimers in erythrocytes of diabetic subjects 101
Plasma F2-isoprostanes are elevated in newborns and inversely correlated to the gestational age 101
Subclinical myocardial dysfunction in Rett syndrome 101
The role oh hypoxia on U-373 MG astrocytes 100
Release of free, redox-active iron in the liver and DNA oxidative damage following phenylhydrazine intoxication 99
Partial rescue of Rett syndrome by ω-3 polyunsaturated fattyacids (PUFAs) oil 96
Synaptosome behavior is unaffected by weak pulsed electromagnetic fields 95
Oxidative stress in Rett Syndrome: natural history, genotype and variants 93
Oxidative stress: a hallmark of Rett syndrome 93
The effect of hypoxia on free iron and F2-isoprostanes levels in rat cortical synaptosomes 91
Variations in the fatty acid composition of rat erythrocyte membrane lipids at different ages [Variazione della composizione in acidi grassi dei lipidi della membrana dell'eritrocita nel ratto a differente eta'] 90
Intraerythrocyte non-protein-bound iron release and diffusion after in vitro hypoxia reoxygenation 89
Livelli plasmatici di endotelina-1 ed ossido nitrico in soggetti diabetici 89
Hypoxia induces iron release by cortical synaptosomes 88
Relationships between Lipid and Purine Metabolism - The Behavior of Fatty Aacid in the Plasma Triglycerides of Gouty Patients 88
Iron release and biochemical and morphological alterations in eryhtrocytes 87
Variations in erythrocyte enzymatic activity in the first days of life [Variazioni di attività enzimatiche eritrocitarie nei primi giorni di vita] 84
Iron release in newborn and adult erythrocytes exposed to hypoxia-reoxygenation 82
Totale 13.171
Categoria #
all - tutte 47.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.032 0 0 0 0 203 239 276 427 285 313 68 221
2020/20212.251 134 256 92 236 83 269 85 326 223 208 177 162
2021/20221.482 128 155 88 123 68 38 87 123 112 135 134 291
2022/20232.181 134 144 308 280 243 447 40 216 204 51 73 41
2023/20241.437 64 34 158 51 38 403 508 31 10 24 17 99
2024/2025743 70 159 277 167 70 0 0 0 0 0 0 0
Totale 14.278